Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010602 |
---|---|
Receipt number | R000012389 |
Scientific Title | Randomized phase IIb/III trial of autologous tumor vaccine with temozolomide for newly diagnosed glioblastoma. |
Date of disclosure of the study information | 2013/04/26 |
Last modified on | 2021/09/15 18:08:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/26 18:53:40 | ||
2 | Update | 2014/10/28 20:03:11 | Email Address Address TEL Co-sponsor Institutions |
|
3 | Update | 2021/09/15 17:42:45 | Number of participants that the trial has enrolled |
|
4 | Update | 2021/09/15 18:08:53 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date analysis concluded |